Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications increasingly prescribed in the UK for type 2 diabetes management and, in specific cases, for weight management in adults with obesity
Discharge rate : How much capacity the aircraft draws from battery per second
1 Morgan Stanley, Could Obesity Drugs Take a Bite Out of the Food Industry, 2023 2 Morgan Stanley, 2023 3 The Food Institute, 2024 4 Nestle, First-to-market Vital Pursuit Hits Shelves Nationwide, 2024 5 Grocery Dive, How GLP-1s Could Reshape the Grocery Store, 2025 6 MediaRadar, Weight Loss, Diabetes Drug Ad Spending Tops $1B, 2024 7 McKinsey, What are GLP-1 Medications?, 2025 8 JP Morgan Research, The Increase in Appetite for Obesity Drugs, 2023 9 Cornell University, The No-Hunger Games: How GLP-1 Medication Adoption is Changing Consumer Food Demand, 2024
Similar to priority products, the provisional determination may be granted to either a new medicine or a new indication where no alternative products are registered for the condition or when preliminary data shows that the provisional product constitutes a substantial improvement in safety or efficacy
, , , , POLEZNOO.RU
